logo
welcome
Yahoo

Yahoo

Weight loss drugs like Ozempic are all over the news. Here's what I'm reading to keep up as a health reporter.

Yahoo
Summary
Nutrition label

71% Informative

Millions of Americans have taken the drugs, known collectively as GLP-1 agonist medications.

Their potential benefits, well beyond treating obesity and diabetes, continue to mount as research pours in.

But so do concerns over everything from cost to rare but life-threatening risks.

Meanwhile, Eli Lilly has said that shortages of its drugs Zepbound and Mounjaro will soon be over. Eli Lilly’s new plan for distributing Zepbound in vials may help to alleviate supply strain too. The company is also going to court to try to stop compounding pharmacies from making cheaper copies of its drugs, which is only legal amid shortages. Will all of this help people get their hands on the drugs or make it even harder? We’ll see. [ Washington Post ].